Skip to main content
. Author manuscript; available in PMC: 2013 Mar 14.
Published in final edited form as: J Rheumatol. 2012 Jun 1;39(7):1392–1398. doi: 10.3899/jrheum.111196

Table 1.

Demographic characteristics of patients in the Hopkins Lupus Cohort (n = 2102). Data are n (%) unless otherwise indicated.

Characteristics Total Cohort, n = 2102 White, n = 1183 African American, n = 780 Other Ethnicities, n = 139
Age at SLE onset, yrs, mean (SD) 29.4 (12.7) 29.6 (13.3) 29.6 (11.8) 26.4 (11.8)
Age at SLE diagnosis, yrs, mean (SD) 32.6 (12.9) 33.7 (13.4) 31.7 (12.0) 28.7 (12.4)
Age at last assessment, yrs, mean (SD) 42.9 (13.5) 43.7 (13.7) 42.8 (13.2) 36.9 (12.2)
Disease duration from SLE diagnosis to last visit, yrs, mean (SD) 10.8 (8.2) 10.5 (7.9) 11.5 (8.9) 8.9 (6.2)
Sex
    Women 1940 (92.3) 1082 (91.5) 727 (93.2) 131 (94.2)
    Men 162 (7.7) 101 (8.5) 53 (6.8) 8 (5.8)
Ethnicity
    White 1183 (56.3)
    African American 780 (37.1)
    Other 139 (6.6)
Photosensitivity 1129 (53.9) 740 (62.9) 323 (41.5) 66 (47.5)
Arthritis 1540 (73.8) 840 (71.6) 605 (78.1) 95 (68.8)
Neurologic 78 (3.8) 35 (3.0) 40 (5.2) 3 (2.2)
Serositis 1034 (49.2) 548 (46.4) 422 (54.1) 64 (46.0)
Renal 879 (42.1) 370 (31.5) 434 (56.0) 75 (54.0)
Anti-dsDNA 1322 (63.1) 702 (59.6) 517 (66.3) 103 (74.6)
Low complement 1298 (57.5) 680 (57.5) 501 (64.3) 117 (84.2)
Anticardiolipin antibodies 966 (47.6) 551 (48.3) 351 (46.8) 64 (46.4)
Lupus anticoagulant 537 (26.5) 326 (28.5) 177 (23.6) 34 (25.2)
Raynaud's phenomenon 1094 (52.2) 654 (55.5) 377 (48.4) 63 (45.7)